AGENDA

TUESDAY, NOVEMBER 12

8:00am // BREAKFAST AND REGISTRATION

9:00am // OPENING REMARKS

9:00am // KEYNOTE TALK - FRED FRANK, GENENTECH / ROCHE MERGER
10:00am // Corporate Presentation - Aleta Biotherapeutics

10:20am // Corporate Presentation - HYD Pharma

10:40am // Corporate Presentation - Incysus

11:00am // Corporate Presentation - Pacylex

11:20am // Corporate Presentation - Intervention Insight

11:40am // Corporate Presentation - Paragon Genomics

12:00pm // Corporate Presentation - EnGeneIC Limited
12:20 pm //  Corporate Presentation - Cell Vault

12:45pm // GRAB LUNCH 

12:55pm // LUNCH PANEL - Company Valuations and Inflection Points

                     Moderator: Mark Wicker, Firmwide Chair, Biotechnology & Pharmaceutical Industry Group, Perkins Coie
                     (David Stover, Frm SVP Research Astellas, CEO Nammi | Dennis Purcell, Founder of Aisling Capital | Adrian Rich, Partner Perkins Coie)

1:35pm // Corporation Presentation - ChemioCarw
1:55pm // Corporation Presentation - SynDevRx

2:15pm // Corporation Presentation - Travera

2:35pm // Corporation Presentation - Cognos Therapeutics

2:55pm // Corporation Presentation - Cambium

3:15pm // Corporation Presentation - Faron Pharmaceuticals

3:35pm // Corporation Presentation - Lumicell

3:55pm // PANEL - Opportunity and Developments in Immunotherapy and T-Cell Therapy

                   Moderator: Paul Abrams, ICIF/NFCR
                   (Renier Brentjens, Director of Cellular Therapies at Memorial Sloane | Alfred Slanetz, Frm Bluebird Bio CEO, Current Geneius CEO)

4:30pm // Corporation Presentation - pHLIP

4:50pm // Corporation Presentation - Avita Biomedical

5:10pm // Corporation Presentation - Seneca Therapeutics

5:30pm // Corporation Presentation - Agilvax

5:50pm // Corporation Presentation - Immunophotonics

6:10pm // Corporation Presentation - Soligenix

6:30pm // Corporation Presentation - Sermonix Pharmaceuticals

6:50pm // Corporate Presentation - Hemogenyx

7:10pm - 9:00 // Reception - Dinner and Drinks

WEDNESDAY, NOVEMBER 13

8:00am // BREAKFAST

9:00am // TALK - DR. LYNDA CHIN (Founder Genomics Department at MD Anderson, CEO Apricity) Predicting and Managing Toxicities Related to Immunotherapies

9:30am // Corporate Presentation - BioMarck Pharmaceuticals

9:50am // Corporate Presentation - SIWA Therapeutics

10:10am // Corporate Presentation - Bionetix

10:30am // Corporate Presentation - KIYATEC

10:50am // Corporate Presentation - Cellestia Biotech

11:10am // Corporate Presentation - LexentBio

11:30am // Corporate Presentation - Pionyr Immunotherapeutics

11:50am // Corporate Presentation - Oncovir

12:10pm // GRAB LUNCH

12:25pm // LUNCH PANEL - INTELLECTUAL PROPERTY VALUATION AND DUE DILIGENCE
                     Michael Wise, Firmwide Chair, Life Sciences & Healthcare Sector, Perkins Coie
                     (John Friedman, Founder Easton Capital/Gore Range Capital | Alfred Slanetz, Frm CEO Bluebird Bio, Current Geneius CEO
                     Peter Gombrich, Co-Founder St. Jude Medical)

1:00pm // Corporate Presentation - EpiVax Oncology

1:20pm // Corporate Presentation - Cue

1:40pm // Corporate Presentation - 20/20 Gene Systems

2:00pm // Corporate Presentation - Shuttle Pharmaceuticals

2:20pm // Corporate Presentation - Proscia

2:40pm // Corporate Presentation - Arrien Pharmaceuticals

3:00pm // Corporate Presentation - NBE Therapeutics

3:20pm // BREAK

3:30pm // Corporate Presentation - Imago

3:50pm // Corporate Presentation - ImpriMed

4:10pm // Corporate Presentation - Treos Bio

4:30pm // Corporate Presentation - Geneius Biotechnology
4:50pm // Corporate Presentation - SageMedic
5:10pm // Corporate Presentation - OTraces
5:30pm // Corporate Presentation - Nammi

5:50pm // Corporate Presentation - Oncogenesis

6:10pm // Reception - Drinks (Sponsored by US Capital Global)
 

© 2019 Oncology Investor Conference Series